Transplantable Syngeneic Rodent Tumors

Abstract

Cancer researchers have made significant progress over the years by developing appropriate and accurate animal disease models, the most important being transplantable rodent tumors. In Tumor Models in Cancer Research, Beverly A. Teicher and a panel of leading experts comprehensively describe for the first time in many years the state-of-the-art in tumor model research. The wide array of model systems detailed form the basis for the selection of both compounds and treatments that go into clinical testing of patients, and include syngeneic, human tumor xenograft, orthotopic, metastatic, transgenic, and gene knockout models. These models represent the efforts of many investigators over the years and approach, with increasing precision, examples that serve as guides for the selection of agents and combinations for the treatment of human malignancy. Synthesizing many years of experience with all the major in vivo models currently available for the study of malignant disease, Tumor Models in Cancer Research provides preclinical and clinical cancer researchers alike with a comprehensive guide to the selection of these models, their effective use, and the optimal interpretation of their results. I: Introduction -- 1 Perspective on the History of Tumor Models -- II: Transplantable Syngeneic Rodent Tumors -- 2 Murine L1210 and P388 Leukemias -- 3 Transplantable Syngeneic Rodent Tumors: Solid Tumors in Mice -- 4 B16 Murine Melanoma: Historical Perspectiveon the Development of a Solid Tumor Model -- III: Human Tumor Xenografts -- 5 Xenotransplantation of Human Cell Cultures in Nude Mice -- 6 GFP-Expressing Metastatic-Cancer Mouse Models -- 7 Human Tumor Xenografts and Explants -- IV: Carcinogen-Induced Tumors: Models of Carcinogenesis and Use for Therapy -- 8 Hamster Oral Cancer Model -- 9 Mammary Cancer in Rats -- 10 Carcinogen-Induced Colon-Cancer Models for Chemoprevention and Nutritional Studies -- V: Mutant, Transgenic, and Knockout Mouse Models -- 11 Cancer Models: Manipulating the Transforming Growth Factor-? Pathway in Mice -- 12 Cyclin D1 Transgenic Mouse Models -- 13 Mice Expressing the Human Carcinoembryonic Antigen: An Experimental Model of Immunotherapy Directed at a Self, Tumor Antigen -- 14 The p53-Deficient Mouse as a Cancer Model -- 15 The Utility of Transgenic Mouse Models for Cancer Prevention Research -- VI: Metastasis Models -- 16 Metastasis Models: Lungs, Spleen/Liver, Bone, and Brain -- 17 Models for Evaluation of Targeted Therapies of Metastatic Disease -- VII: Normal Tissue Response Models -- 18 Animal Models of Oral Mucositis Induced by Antineoplastic Drugs and Radiation -- 19 The Intestine as a Model for Studying Stem-Cell Behavior -- 20 SENCAR Mouse-Skin Tumorigenesis Model -- 21 Murine Models of Bone-Marrow Transplant Conditioning -- 22 Anesthetic Considerations for the Study of Murine Tumor Models -- VIII: Disease and Target-Specific Models -- 23 Tissue-Isolated Tumors in Mice: Ex Vivo Perfusion of Human Tumor Xenografts -- 24 Human Breast-Cancer Xenografts as Models of the Human Disease -- 25 Animal Models of Melanoma -- 26 Experimental Animal Models for Renal Cell Carcinoma -- 27 Animal Models of Mesothelioma -- 28 SCID Mouse Models of Human Leukemia and Lymphoma as Tools for New Agent Development -- 29 Models for Studying the Action of Topoisomerase-I Targeted Drugs -- 30 Spontaneous Pet Animal Cancers -- IX: Experimental Methods and End Points -- 31 In Vivo Tumor Response End Points -- 32 Tumor-Cell Survival -- 33 Apoptosis In Vivo -- 34 Transparent Window Models and Intravital Microscopy: Imaging Gene Expression, Physiological Function, and Drug Delivery in Tumors.